Memo
Overview
Memo is a scientific journal, published since 2008 in English. The journal's country of origin is Austria and its primary focus area is hematology.
Details
Details
Abbr.
Memo
Start
2008
End
Continuing
Frequency
Quarterly
p-ISSN
1865-5041
e-ISSN
1865-5076
Country
Austria
Language
English
Specialty
Hematology
Metrics
Metrics
h-index / Ranks: 12197
21
SJR / Ranks: 12311
271
CiteScore / Ranks: 11773
1.50
Recent Articles
1.
Bronimann S, Singla N, Korn S, Huebner N, Shariat S
Memo
. 2024 Aug;
17(1):40-44.
PMID: 39092435
Introduction: Metastatic hormone-sensitive prostate cancer (mHSPC) displays both simultaneous and sequential patterns of metastasis, emphasizing a comprehensive treatment approach that integrates both local therapy and systemic treatment strategies. The increasing...
2.
3.
4.
Huf W, Valipour A
Memo
. 2023 Jan;
16(1):73-78.
PMID: 36628356
Compared to individuals without cancer, patients with a diagnosis of malignancy bear a higher risk of becoming infected with SARS-CoV‑2, suffer more frequently from disease-related complications, and are more likely...
5.
6.
7.
8.
Feichtner A, Kugler V, Schwaighofer S, Nuener T, Fleischmann J, Stefan E
Memo
. 2022 Jun;
15(2):137-142.
PMID: 35677701
Numerous kinases act as central nodes of cellular signaling networks. As such, many of these enzymes function as molecular switches for coordinating spatiotemporal signal transmission. Typically, it is the compartmentalized...
9.
Suppan C
Memo
. 2022 May;
15(2):111-113.
PMID: 35540707
The congress of the European Society of Medical Oncology (ESMO) that recently took place virtually was marked by highlights in many different cancer types. New therapeutic options especially in metastatic...
10.
Weiss L
Memo
. 2022 May;
15(2):114-116.
PMID: 35505999
This short review reflects on a personal selection of three abstracts on colorectal cancer (CRC) presented at the 2021 ESMO Congress: (1) KRASG12C as a new therapeutic target in metastatic...